White Paper: What Does Your Plant Spend On Raw Material ID? The Answer May Surprise You
Source: Thermo Scientific (formerly Ahura Scientific)
Drug manufacturers must verify the identity (ID) of their incoming raw materials prior to release into the production process. For some, meeting this requirement involves extracting and testing samples from a small fraction of their incoming containers; for others it means testing every single package. Regardless, all find thorough and compliant material ID a costly exercise, with costs that span operational, personnel, facility planning, capital equipment, maintenance and consumables. Just how costly can it get? Submitted by Ahura Scientific
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more